Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 40% ± 19% | |
astrocyte | 10 studies | 30% ± 17% | |
oligodendrocyte precursor cell | 10 studies | 29% ± 15% | |
GABAergic neuron | 8 studies | 36% ± 17% | |
interneuron | 7 studies | 39% ± 22% | |
neuron | 4 studies | 21% ± 4% | |
GABAergic interneuron | 3 studies | 23% ± 4% | |
adipocyte | 3 studies | 30% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 28% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 154.23 | 2635 / 2642 | 63% | 1.48 | 447 / 705 |
kidney | 100% | 936.91 | 89 / 89 | 40% | 1.54 | 358 / 901 |
liver | 86% | 276.75 | 195 / 226 | 48% | 8.88 | 193 / 406 |
ovary | 80% | 36.22 | 144 / 180 | 13% | 0.21 | 57 / 430 |
thymus | 53% | 13.95 | 345 / 653 | 21% | 0.31 | 130 / 605 |
adrenal gland | 7% | 2.11 | 18 / 258 | 40% | 1.05 | 91 / 230 |
prostate | 39% | 10.84 | 95 / 245 | 2% | 0.03 | 8 / 502 |
breast | 29% | 6.71 | 133 / 459 | 4% | 0.07 | 40 / 1118 |
uterus | 23% | 4.72 | 39 / 170 | 1% | 0.04 | 3 / 459 |
lung | 6% | 1.16 | 33 / 578 | 2% | 0.04 | 21 / 1155 |
adipose | 7% | 1.57 | 84 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 5% | 1.04 | 71 / 1335 | 0% | 0 | 0 / 0 |
spleen | 4% | 1.23 | 10 / 241 | 0% | 0 | 0 / 0 |
intestine | 3% | 0.63 | 33 / 966 | 0% | 0.00 | 2 / 527 |
skin | 2% | 0.28 | 28 / 1809 | 1% | 0.02 | 3 / 472 |
stomach | 0% | 0.04 | 1 / 359 | 2% | 0.02 | 5 / 286 |
esophagus | 1% | 0.24 | 21 / 1445 | 1% | 0.01 | 1 / 183 |
heart | 1% | 0.25 | 12 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.04 | 2 / 178 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.02 | 5 / 504 |
peripheral blood | 1% | 0.19 | 9 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.02 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009116 | Biological process | nucleoside metabolic process |
GO_0006218 | Biological process | uridine catabolic process |
GO_0044206 | Biological process | UMP salvage |
GO_0046108 | Biological process | uridine metabolic process |
GO_0006249 | Biological process | dCMP catabolic process |
GO_0045098 | Cellular component | type III intermediate filament |
GO_0005829 | Cellular component | cytosol |
GO_0004850 | Molecular function | uridine phosphorylase activity |
GO_0047847 | Molecular function | deoxyuridine phosphorylase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | UPP2 |
Protein name | Uridine phosphorylase (EC 2.4.2.3) Uridine phosphorylase 2 (UPase 2) (UrdPase 2) (EC 2.4.2.3) Uridine phosphorylase 2 isoform 3 Uridine phosphorylase 2 isoform 4 |
Synonyms | |
Description | FUNCTION: Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis . Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds . . FUNCTION: Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis. Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds. . FUNCTION: Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis. Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds. . |
Accessions | A0A0S2Z698 ENST00000005756.5 [O95045-1] A0A0S2Z639 A0A0S2Z6U5 O95045 ENST00000605860.5 [O95045-2] A0A0S2Z634 |